Skip to main content
Premium Trial:

Request an Annual Quote

Calyxt Licenses Plant Gene-Targeting IP from U of Minnesota

NEW YORK (GenomeWeb) – Plant genome engineering firm Calyxt yesterday announced it has signed an exclusive license agreement with the University of Minnesota for worldwide rights to intellectual property for gene targeting.

Calyxt now has rights to a family of patents entitled "Gene Targeting in Plants Using DNA Viruses." The technology is based on a group of DNA viruses known as geminiviruses and enables efficient targeted modification of plant genomes in conjunction with customizable endonucleases, the firm said in a statement.

According to the patent application, the method is "the first account demonstrating concurrent use of [geminiviruses and endonucleases] as a gene targeting methodology, which is likely to have vast implications in all areas of plant biology."

Financial and other details of the deal were not disclosed.

University of Minnesota professor Dan Voytas developed the technology in his laboratory at the school. Voytas is also chief science officer at Calyxt.

New Brighton, Minnesota-based Calyxt is formerly known as Cellectis Plant Sciences. In April, the firm licensed CRISPR/Cas9 gene editing technology that Voytas developed at the University of Minnesota.

The Scan

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.

Meta AI Computer Model Rapidly Predicts Hundreds of Millions of Metagenomic Proteins

Meta AI researchers describe in Science a new large language model that can predict the structures of millions of metagenomic proteins.

Hutch Team Develops Platform for Assessing Impact of SARS-CoV-2 Spike Mutations

The approach described in Cell relies on lentiviral pseudotyping for mutational scanning, which the researchers applied to the SARS-CoV-2 spike protein.

Potential New Therapeutic Target for Rheumatoid Arthritis Discovered

Researchers report in the American Journal of Human Genetics that SNPs implicated in rheumatoid arthritis often regulate the expression of the inflammation-related SPRED2 gene.